Background: Environmental lead and cadmium exposure is associated with higher risk
INTRODUCTION
Frailty is a geriatric syndrome characterized by a decreased ability to cope with acute stressors resulting from aging-related decline in reserve and function of multiple physiologic systems, including the cardiovascular, metabolic, immune, endocrine, or nervous systems (Clegg et al. 2013) . The progressive accumulation of deficits in these systems increases the risk of disease onset and leads to a cycle of events (i.e. undernutrition, sarcopenia, diminished strength or exercise intolerance) that perpetuate frailty. With the addition of new stressors, the cycle of frailty can easily progress to disability (Vermeulen et al. 2011) , institutionalization (Fried et al. 2001 ) and death (Graham et al. 2009; Song et al. 2010) . Given the serious consequences of frailty and its high frequency, which reaches 10% of individuals over 60 years and 25% of those over 80 (Clegg et al. 2013 ), extensive research is being conducted to determine why some older adults become frail, and to identify preventable risk factors and mechanistic pathways. Despite this effort, few studies have evaluated the role of environmental contaminants on the risk of frailty, and most of them have focused on the effects of air pollution (Eckel et al. 2012; Myers et al. 2013 ).
The Environmental Protection Agency (EPA) has identified common environmental exposures that may especially harm the health of older adults, including metals, pesticides, water contaminants or air particles. For some contaminants (i.e. organic pollutants, certain metals) this increased risk may be related to bioaccumulation over the lifetime. Higher vulnerability in older adults may also partly result from age-related alterations in cellular function which impair the capability to maintain physiologic homeostasis (Geller and Zenick 2005) . Additionally, aging is associated with major changes in body composition that could influence the absorption and distribution of environmental chemicals in human tissues (Nordberg et al. 2007 ).
Lead and cadmium are two toxic metals widely distributed in the environment that accumulate in the human body, resulting in chronic endogenous exposure tissues (Nordberg et al. 2007) . Increasing evidence supports the contribution of environmental lead and cadmium to the development of several age-related chronic diseases, including cardiovascular disease (Navas-Acien et al. 2007; Tellez-Plaza et al. 2013b) , chronic kidney disease (Navas-Acien et al. 2009 ), and osteoporosis (Engstrom et al. 2011; Gallagher et al. 2008; Khalil et al. 2008) . Despite this evidence, and the established connection between these diseases and the frailty syndrome (Heuberger 2011) , no previous studies have examined the association between lead or cadmium exposure and frailty. To evaluate this question, we used data from the third US National Health and Nutrition Examination Survey (NHANES III). We hypothesized that increasing concentrations of blood lead or urine cadmium are associated with increasing frequency of frailty in older adults.
METHODS

Study participants
NHANES III was a multistage, stratified, clustered probability survey of the US civilian non-institutionalized population, conducted between 1988 and 1994 by the National Center for Health Statistics. The survey consisted of a household interview and a standardized physical examination performed in a mobile center. Our analysis was initially limited to adults ≥60 years of age who had completed the physical examination (N=5,724). For our study, we further restricted the sample to participants who had either blood lead or urine cadmium determinations available (N=5,579). The study was approved by the NHANES Institutional Review Board (IRB), and written informed consent was obtained from all subjects.
Study variables
Lead and Cadmium
Blood and spot urine samples were collected during the physical examination. All collection and storage materials used for metal analysis were prescreened for background contamination levels. Blood lead concentrations were measured by graphite furnace atomic absorption spectrophotometry. The limit of detection (LOD) for blood lead was 1 µg/dl and the interassay coefficients of variation ranged from 2.78 to 8.11%.
For 2.8% of the participants with blood lead concentrations under the LOD, these were replaced by the LOD divided by the squared root of 2.
Urine cadmium was measured by Zeeman effect graphite furnace atomic absorption.
The LOD for cadmium was 0.03 µg/dl and the interassay coefficients of variation ranged from 2.83 to 13.57%. Cadmium was undetectable for 2.5% of the participants and the levels replaced by the LOD divided by the square root of 2. To account for urine dilution, cadmium levels were either adjusted or divided by urine creatinine (µg/g).
Additional details regarding laboratory procedures have been described in detail (Gunter et al. 1996) .
Frailty
Assessment of frailty was performed using a modification of the definition developed by Fried and colleagues (Fried et al. 2001) in the Cardiovascular Health Study (CHS).
Individuals meeting ≥3 of the following criteria were considered as frail: 1) Exhaustion, defined as any of these responses "some difficulty", "much difficulty" or "unable to do it" to the question "How much difficulty do you have walking from one room to the other on the same level?"; 2) Low body weight, characterized by a body mass index (BMI) ≤18 kg/m 2 ; 3) Low physical activity, considered present if the individual answered "less active" to the following question: "When compared to most men/women of your age, would you say that you are more active, less active or about the same?"; 4)
Weakness, defined as any of these responses "some difficulty", "much difficulty" or "unable to do it" to the question "How much difficulty you have lifting or carrying something as heavy as 10 pounds? "; 5) Slow walking speed, defined as the worse quintile in the eight-foot walking speed test, adjusted for sex and height (Guralnik et al. 1994) . The main modifications with respect to the CHS definition of frailty were that the nutrition criterion was based on low BMI rather than on weight loss in the preceding months, and that weakness was self-reported rather than based on the direct assessment of grip strength; similar modifications are common in the frailty literature, and usually result from the information available in each dataset.
Other variables
We collected data from a number of variables (gender, age, education, race/ethnicity, tobacco smoking, number of smokers at home and number of drug treatments used) that may act as potential confounders because they have shown to be independently associated with the outcome (Fried et al. 2001; Mello Ade C et al. 2014) and with the exposure (Nordberg et al. 2007 ). Additionally, participants were asked about medical conditions that could be acting as mediators of the studied association (i.e previous history of cardiovascular disease (congestive heart failure, coronary heart disease, angina or stroke), hypertension, diabetes, osteoarticular disease (osteoporosis, rheumatoid arthritis and osteoarthritis), respiratory disease (asthma, chronic bronchitis or emphysema) and cancer).
Weight and height were measured in standardized conditions, and BMI was calculated as weight in kg divided by squared height in m. During the medical examination, blood pressure was measured three times with the participant seated for 5 minutes and using an appropriate sized cuff. Hypertension was defined as self-reported physician diagnosis of high blood pressure or a mean systolic/diastolic blood pressure ≥140/90 mm Hg.
Serum creatinine was measured using the modified kinetic Jaffe reaction, with a coefficient of variation that ranged between 0.2 and 1.4%. Chronic kidney disease was defined as a glomerular filtration rate (GFR) < 60 mL/min per 1.73 m 2 , estimated using the CKD-EPI equation (Levey et al. 2009 ). Serum cotinine was measured using high performance liquid chromotography/atmospheric pressure chemical ionization tandem mass spectrometry. The LOD for serum cotinine using this method was 0.05 ng/ml and values under the LOD were replaced by the square root of 2.
Statistical analyses
From the initial sample size of 5,579 individuals, we excluded 85 with missing values in ≥3 frailty domains and 86 with missing data on potential confounders (44 on education, 5 on BMI, 5 on the number of smokers at home, 28 on self-reported chronic conditions, and 4 on number of drug treatments). From the remaining 5,408 participants, for lead analyses we excluded 136 individuals who lacked data on blood lead and for cadmium analyses we excluded 521 subjects without data on urine cadmium. This led to a final analytical sample of 5,272 (94.5%) and 4,887 (87.6%) adults for blood lead and urine cadmium analyses, respectively. Study participants were similar in sociodemographic and frailty risk factors to the overall study population (data not shown).
The association of blood lead and urine cadmium concentrations with frailty or its components was evaluated with odds ratios (OR) and their 95% confidence interval (CI)
obtained from logistic regression. Three logistic models were built. Model 1 was unadjusted. Model 2 was adjusted for sex and age, and model 3 was additionally adjusted for educational level, ethnicity, BMI, tobacco smoking (never/former/current), number of smokers at home, cardiovascular disease, hypertension, diabetes, osteoarticular disease, respiratory disease, cancer and number of drug treatments. In the analyses, lead and cadmium were classified into tertiles, with the lowest tertile being the exposure reference. We also modeled ln-transformed lead and ln-transformed cadmium as continuous variables, and expressed the results per intertertile range increase in lnmetal concentrations. In addition, we modeled lead and cadmium as restricted cubic splines with knots at the 10 th , 50 th and 90 th percentiles.
We conducted a number of sensitivity analyses to assess the robustness of the results.
First, to account for current exposure to tobacco smoke, including secondhand smoke, that is a source of lead and cadmium (Apostolou et al. 2012; Tellez-Plaza et al. 2012 Statistical analyses were performed with the STATA v.13.0 software (Stata Corp, College Station, TX) by using the survey procedures to account for the complex sampling design in NHANES III
RESULTS
The median (intertertile range) concentrations of blood lead and urine cadmium were 3.9 µg/dl (2.9-4.9) and 0.62 µg/l (0.41-0.91), respectively. Blood lead concentrations were higher among men, non-Hispanic black, participants with lower education or lower BMI, ever smokers, those living with at least one smoker, as well as in those with decreased GFR and chronic respiratory disease ( In spline regression models (figure 1), the dose-response relationship was progressive over the range of blood lead concentrations (p value for the nonlinear component=0.46), while the association with cadmium showed a nonlinear pattern (p values for the nonlinear component <0.01 in model B among the total study sample, and 0.03 in model C among individuals with normal GFR).
The most prevalent frailty components were weakness and slowness, while low BMI was the least frequent. Figure 2 presents In interaction analyses, results for lead were consistent across all participant´s subgroups evaluated, including smoking status and cotinine concentrations (figure 3).
Similarly, no effect modification by morbidity status was observed. We were particularly interested in evaluating potential effect modification by osteoporosis, as lead is stored in bones. The association of lead with frailty was somewhat stronger among women with osteoporosis: the OR (95% CI) for frailty for the second and third tertiles compared to the lowest one were: 1.86 (1.06-3.28) and 4.23 (1.64-10.88) in women with osteoporosis and 1.40 (0.87-2.27) and 2.12 (1.00-7.41) in women without osteoporosis (p interaction: 0.23). For cadmium, there was effect modification by tobacco smoking (p=0.02), with results suggesting that a positive association between this metal and frailty may be limited to current smokers (OR of frailty for an intertertile increase in urine cadmium among smokers: 2.85; 95%CI: 1.00-8.14 in individuals with normal GFR). No changes in the results were observed when lead models were adjusted for cadmium or when cadmium levels were adjusted for lead.
DISCUSSION
In the US older adult population, blood lead concentrations showed a positive doseresponse relationship with frailty. For cadmium, no overall association with frailty was found but there was was some evidence of a putative adverse relationship only at high exposure levels.
Lead and cadmium may influence the risk of frailty through several mechanisms. (Gale et al. 2013; Li et al. 2011) ). Second, exposure to lead and cadmium has been related to a higher risk of several pathologic conditions that are also linked to frailty. Environmental exposure to lead in the elderly has been associated with cognitive decline (Bandeen-Roche et al. 2009; Grashow et al. 2013; Nordberg et al. 2000; Power et al. 2014; Shih et al. 2006; van Wijngaarden et al. 2011) , impaired motor skills (Grashow et al. 2013) , increased blood pressure (Perlstein et al. 2007 ), ischemic heart disease (Jain et al. 2007 ), decreased renal function (Tsaih et al. 2004 ), falls and fractures in women (Khalil et al. 2008) , hearing loss (Park et al. 2010 ) and vision problems (Schaumberg et al. 2004; Wu et al. 2014) . Cadmium, for which fewer studies have been conducted in the elderly, has also been associated with an increased risk of atherosclerotic plaques (Fagerberg et al. 2012) , peripheral artery disease (Tellez-Plaza et al. 2013a), osteoporosis (Engstrom et al. 2011; Gallagher et al. 2008 ) and macular degeneration (Shiue 2013; Wu et al. 2014) . In addition, a decrease in muscle mass and muscle strength, which are components of frailty (Cesari et al. 2006) , might also contribute to the observed associations. Thus, to explore this possibility in the study sample, we estimated muscle mass with the formula proposed by Janssen et al. (2002) and observed that a 1% increase in blood lead concentrations was associated with a decrease of 0.72% (95%CI -1.27; -0.16) in muscle mass, while a 1% increase in urine cadmium was linked to a reduction of 0.65% (95%CI -1.24; -0.07). These findings suggest that lead and cadmium could increase the risk of frailty through alterations in the musculoskeletal system.
No previous study has evaluated the association between heavy metals and frailty.
However, two reports from the continuous NHANES (1999) (2000) (2001) (2002) (2003) (2004) have explored the link of blood lead (Ji et al. 2013 ) and urine cadmium (Lang et al. 2009 ) with mobility outcomes among the elderly population. The first of these studies (Ji et al. 2013) ,
reported that walking speed decreased with increasing blood lead concentrations in women, but not in men. Contrary to these results, we found an association between blood lead concentrations and low gait speed in both men and women (data not shown).
The second study (Lang et al. 2009 ) found a positive crude association between urine cadmium and "self-reported problems with walking a quarter of a mile", but this association was not maintained after adjustment for urine creatinine. Lastly, in the VA Normative Aging Study, bone lead concentration was associated with reduced fine motor performance over a 30-month follow-up (Grashow et al. 2013 ).
More than 90% of lead is accumulated in the bones, from where it can be released to blood. Blood lead, the most commonly used biomarker of lead exposure, has a relatively short half-life, and reflects both recent exogenous exposure as well as chronic exposure from mobilization of bone stores tissues (Skerfving and Bergdahl 2007) .
Under conditions of accelerated bone turnover and mineral loss (i.e. postmenopausal osteoporosis; ageing-related loss of bone mass), lead stored in bones throughout life is released into circulation, increasing the correlation between blood lead concentrations and chronic exposure, as measured by patella lead levels (Tsaih et al. 2001) . In this sense, it is interest to note that the magnitude of the observed effects in our population tended to be higher among older individuals and among women who had been previously diagnosed with osteoporosis, although effect modification was not statistically significant.
Cadmium is a cumulative element with a biological half-life of more than 10 years, and urine cadmium is a good biomarker of long-term exposure (Jarup and Akesson 2009) .
Recent studies have suggested that cadmium bioaccumulation may only occur until age 60, when urine cadmium concentrations would level off or even decrease due to physiological variations in renal function (Chaumont et al. 2013 ). It is difficult to anticipate how these variations with age could affect the interpretation of our results. In any case, given that the association between cadmium and frailty disappeared after excluding participants with reduced GFR, it is possible that the observed results in the total study sample reflected the underlying association between kidney disease and frailty. Accordingly, Wilhelm-Leen and colleagues (2009) recently reported a positive association between chronic kidney disease and frailty using data from the III NHANES. Thus, future prospective studies should exclude individuals with reduced kidney function at study entry. Special attention should be paid to current smokers, in whom the observed association may reflect the combined toxic effect of cadmium and other tobacco chemicals.
Strengths of this study included the large sample, which was representative of the US general population aged ≥ 60 years, the high quality laboratory methods, as well as the number of potential confounders evaluated. However, this study also had several limitations. First, NHANES III was a cross-sectional study so causal relationships cannot be established. However, since blood lead and urine cadmium reflect, at least partially, chronic exposure to these metals, and given that the life expectancy of frail individuals is limited, it is reasonable to assume that the exposures preceded the development of frailty. Second, the study sample did not include institutionalized individuals, so the study results may not apply to this population group. Third, we used a single spot urine sample to measure cadmium concentrations. However, different strategies to account for urine dilution yielded similar results. Moreover, uncertainties in exposure assessment are likely to result in non-differential measurement error and to underestimate the associations. On the other hand, because serum creatinine is released from muscle mass and muscle mass is inversely correlated with frailty, creatinine correction could also be biasing cadmium results. Finally, we used low BMI as an indicator of frailty because the NHANES III lacked information on weight loss.
However, analyses excluding the weight loss criteria from the definition of frailty and considering as frail those with >3 of the 4 remaining criteria, showed the same results.
CONCLUSION
determine the impact of age-related variations in renal function on cadmium excretion in the elderly, the results of this study do not support an overall association between cadmium exposure and frailty. Future prospective studies should confirm the observed results. *Cotinine models are based on the sub-sample of participants with this information available (N=4796 for lead; N=4596 for cadmium).
